Home › Funds › Blue Owl Capital Holdings LP › MPLT

Blue Owl Capital Holdings LP position in MPLT

MAPLIGHT THERAPEUTICS INC · Health Care

Blue Owl Capital Holdings LP reported holding 556,371 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.7M, representing 1.07% of its reported portfolio and ranking #16 among its reported holdings. Blue Owl Capital Holdings LP has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)556.37K sh
Reported value held$5.67M
Portfolio Weight1.07%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's MPLT position evolved

Blue Owl Capital Holdings LP first disclosed a stake in MPLT in Q4 2025 at 327,058 shares (US$5.7M). The position peaked in Q2 2026 at 729,929 shares, worth US$26.2M. Across 4 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 556,371 shares valued at US$5.7M — a reduction of -173,558 shares quarter over quarter.. Notable position changes include a 208% increase in Q1 2026 (shares rose 76% over the following quarter), a 27% trim in Q2 2026 (shares fell 72% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 327.06K $5.74M New
Q1 2026 1.01M $20.45M Add
Q2 2026 729.93K $26.16M Reduce
Q3 2026 556.37K $5.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MPLT and 13F data

MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 101 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MPLT

All MPLT fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held MPLT?

Blue Owl Capital Holdings LP has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Blue Owl Capital Holdings LP's current position in MPLT?

As of Q3 2026, Blue Owl Capital Holdings LP holds 556.37K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $5.67M, representing 1.07% of its reported portfolio and ranking #16.

Has Blue Owl Capital Holdings LP been buying or selling MPLT?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP reduced its position in MPLT. The position peaked in Q2 2026 at 729.93K shares.

Which other funds hold MPLT?

Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 101 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.